Response to: 'Remission or low disease activity as a target in systemic lupus erythematosus' by Ugarte-Gil et al

被引:1
|
作者
Zen, Margherita [1 ]
Doria, Andrea [1 ]
机构
[1] Univ Padua, Dept Med, Rheumatol Unit, I-35128 Padua, Italy
关键词
PROLONGED REMISSION; CAUCASIAN PATIENTS; ACTIVITY STATE; DAMAGE; PREVALENCE; COHORT; SLE;
D O I
10.1136/annrheumdis-2017-212911
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Remission or low disease activity as a target in systemic lupus erythematosus
    Francisco Ugarte-Gil, Manuel
    Wojdyla, Daniel
    Pons-Estel, Guillermo J.
    Pons-Estel, Bernardo A.
    Alarcon, Graciela S.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (01)
  • [2] Is Low Disease Activity Sufficient as a Target in Systemic Lupus Erythematosus? Comment on the Article by Petri et al
    Ugarte-Gil, Manuel F.
    Wojdyla, Daniel
    Pons-Estel, Guillermo J.
    Pons-Estel, Bernardo A.
    Alarcon, Graciela S.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (12) : 2098 - 2099
  • [3] Response to: 'Remission in systemic lupus erythematosus: durable remission is rare' by Wilhelm et al Response
    Wilhelm, Theresa R.
    Magder, Laurence S.
    Petri, Michelle
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (12)
  • [4] Response to: 'Remission in systemic lupus erythematosus: durable remission is rare' by Wilhelm et al
    Nikpour, Mandana
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (12)
  • [5] Is low disease activity sufficient as a target in systemic lupus erythematosus? Comment on the article by Petri et al Reply
    Petri, Michelle
    Magder, Laurence S.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (12) : 2099 - 2099
  • [6] Predicting Remission and Low Disease Activity Attainment in Patients with Systemic Lupus Erythematosus
    Da Mutten, Raffaele
    Cetrez, Nursen
    Lindblom, Julius
    Oon, Shereen
    Nikolopoulos, Dionysis
    Nikpour, Mandana
    Parodis, Ioannis
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4596 - 4597
  • [7] Prospective Comparison of Remission and Lupus Low Disease Activity State - Effect on Disease Outcomes in Systemic Lupus Erythematosus
    Golder, Vera
    Kandane-Rathnayake, Rangi
    Huq, Molla
    Louthrenoo, Worawit
    Luo, Shue-Fen
    Wu, Yeong-Jian
    Lateef, Aisha
    Sockalingam, Sargunan
    Morton, Susan
    Navarra, Sandra V.
    Zamora, Leonid
    Hamijoyo, Laniyati
    Katsumata, Yasuhiro
    Harigai, Masayoshi
    Chan, Madelynn
    O'Neill, Scan
    Goldblatt, Fiona
    Lau, Chak Sing
    Li, Zhan-Guo
    Hoi, Alberta Y.
    Nikpour, Mandana
    Morand, Eric
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [8] Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients
    Reategui-Sokolova, C.
    Rodriguez-Bellido, Z.
    Gamboa-Cardenas, R. V.
    Medina, M.
    Zevallos, F.
    Pimentel-Quiroz, V. R.
    Elera-Fitzcarrald, C.
    Cucho-Venegas, M.
    Pastor-Asurza, C. A.
    Perich-Campos, R.
    Alarcon, G. S.
    Ugarte-Gil, M. F.
    LUPUS, 2019, 28 (11) : 1344 - 1349
  • [9] Treatment Target in Newly Diagnosed Systemic Lupus Erythematosus: The Association of Lupus Low Disease Activity State and Remission With Lower Accrual of Early Damage
    Floris, Alberto
    Piga, Matteo
    Perra, Daniela
    Chessa, Elisabetta
    Congia, Mattia
    Mathieu, Alessandro
    Cauli, Alberto
    ARTHRITIS CARE & RESEARCH, 2020, 72 (12) : 1794 - 1799
  • [10] PREDICTORS OF LOW DISEASE ACTIVITY AND CLINICAL REMISSION FOLLOWING BELIMUMAB TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Parodis, Ioannis
    Johansson, Petter
    Gomez, Alvaro
    Soukka, Sofia
    Emamikia, Sharzad
    Chatzidionysiou, Katerina
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 761 - 761